Europos Sąjunga - lietuvių - EMA (European Medicines Agency)

serb sa - amifampridine phosphate - lambert-eaton myasthenic syndrome; paraneoplastic syndromes, nervous system; nervous system neoplasms; paraneoplastic syndromes; nervous system diseases; autoimmune diseases of the nervous system; neurodegenerative diseases; neuromuscular diseases; neuromuscular junction diseases; immune system diseases; autoimmune diseases; autoimmune diseases of the nervous system; cancer; neoplasms - kiti nervų sistemos vaistai - simptominis lambert-eaton myastheninio sindromo (lems) gydymas suaugusiesiems.

Europos Sąjunga - lietuvių - EMA (European Medicines Agency)

serb sa - amifampridinas - lambert-eaton miaestininis sindromas - kiti nervų sistemos vaistai - simptominis lambert-eaton myastheninio sindromo (lems) gydymas suaugusiesiems.

Europos Sąjunga - lietuvių - EMA (European Medicines Agency)

viiv healthcare bv - dolutegravir - Živ infekcijos - antivirusiniai vaistai sisteminiam naudojimui - tivicay is indicated in combination with other anti-retroviral medicinal products for the treatment of human immunodeficiency virus (hiv) infected adults, adolescents and children of at least 6 years of age or older and weighing at least 14 kg. tivicay is indicated in combination with other anti-retroviral medicinal products for the treatment of human immunodeficiency virus (hiv) infected adults, adolescents and children of at least 4 weeks of age or older and weighing at least 3 kg.

Europos Sąjunga - lietuvių - EMA (European Medicines Agency)

viiv healthcare b.v. - dolutegravir sodium, lamivudine, abacavir (as sulfate) - Živ infekcijos - antivirusiniai vaistai sisteminiam naudojimui - triumeq is indicated for the treatment of human immunodeficiency virus (hiv) infected adults,  adolescents and children  weighing at least 25 kg who are antiretroviral treatment-naïve or are infected with hiv without documented or clinically suspected resistance to any of the three antiretroviral agents in triumeq.

Europos Sąjunga - lietuvių - EMA (European Medicines Agency)

viiv healthcare b.v. - dolutegravir natrio, lamivudine - Živ infekcijos - antivirusiniai vaistai sisteminiam naudojimui - dovato fluorouracilu ir folino žmogaus imunodeficito viruso tipas 1 (Živ-1) infekcijos suaugusieji ir paaugliai, vyresni nei 12 metų amžiaus, sveria ne mažiau kaip 40 kg, nėra žinoma ar įtariama, atsparumą integrase inhibitorių klasės, arba lamivudine.

Europos Sąjunga - lietuvių - EMA (European Medicines Agency)

viiv healthcare b.v. - dolutegravir natrio, rilpivirine hidrochloridas - Živ infekcijos - antivirusiniai vaistai sisteminiam naudojimui - juluca fluorouracilu ir folino žmogaus imunodeficito viruso tipas 1 (Živ-1) infekcija, suaugusiems, kurie yra virologically-nuslopintas (Živ-1 rnr.